CD8+ T cells (CTLs) recognize tumor-associated antigens (TAAs) along with proteins of HLA class I. These cells become differentiated into killer cells, release perforins, and express the apoptotic inducer FasL after expansion. Here, CD8A is linked to neoplasm.